Skip to content
MedsAcross

Medicine

Divalproex 250 mg delayed-release tablet

Divalproex · Oral
Available on requestPrescription onlyUS FDAGeneric name

Divalproex 250 mg delayed-release tablet is a generic prescription medicine for oral use, made by 27 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30° C (59°…

Key facts

Active ingredient (INN)
Divalproex
Brand
Sold under the generic name
Strength
250 mg
Dosage form
Delayed-release tablet
Route
Oral
Packs
100 tablets, 500 tablets, 10 blister pack and 81 more
Manufacturers
Aurobindo PharmaIndiaSun Pharmaceutical IndustriesIndiaDr. Reddy's LaboratoriesIndiaUnichem LaboratoriesIndiaBryant Ranch PrepackBionpharmaUpsher-Smith LaboratoriesRising Pharma Holdings27 labelers on the register
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30° C (59° to 86° F) Repackaged/Relabeled by: Bryant Ranch Prepack, Inc.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
N03AG01 Valproic acid
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
29 July 2008
Identifiers
RxCUI 1099678, 1099625, 1099870DailyMed set ID cd6fe37a-d26d-4ae8-a894-b44878e6bf8e, 3aff8f08-d8e8-cd13-e063-6394a90aa00c, f936b9d0-a58f-4fa5-8db9-752dabb837a6 +37NDC 71335-2277, 72189-636, 0615-8587 +37Application ANDA078597, ANDA078853, ANDA078790 +4

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

A sample of 40 packs from 27 labelers. The register lists 84 packs for this generic presentation, and we confirm the exact pack on the quote.

PackCodeLabelerMarketed since
100 tablet, delayed release in 1 bottle65862-402-01Aurobindo PharmaIndia24 October 2014
500 tablet, delayed release in 1 bottle65862-402-05Aurobindo PharmaIndia24 October 2014
10 blister pack in 1 carton / 10 tablet, delayed release in 1 blister pack65862-402-10Aurobindo PharmaIndia24 October 2014
3000 tablet, delayed release in 1 bottle65862-402-39Aurobindo PharmaIndia24 October 2014
1000 tablet, delayed release in 1 bottle65862-402-99Aurobindo PharmaIndia24 October 2014
100 tablet, delayed release in 1 bottle55111-530-01Dr. Reddy's LaboratoriesIndia29 July 2008
500 tablet, delayed release in 1 bottle55111-530-05Dr. Reddy's LaboratoriesIndia29 July 2008
30 tablet, delayed release in 1 bottle55111-530-30Dr. Reddy's LaboratoriesIndia29 July 2008
10 blister pack in 1 carton / 10 tablet, delayed release in 1 blister pack55111-530-78Dr. Reddy's LaboratoriesIndia29 July 2008
100 tablet, delayed release in 1 bottle62756-797-08Sun Pharmaceutical IndustriesIndia29 July 2008
500 tablet, delayed release in 1 bottle62756-797-13Sun Pharmaceutical IndustriesIndia29 July 2008
1000 tablet, delayed release in 1 bottle62756-797-18Sun Pharmaceutical IndustriesIndia29 July 2008
30 tablet, delayed release in 1 bottle62756-797-83Sun Pharmaceutical IndustriesIndia29 July 2008
100 tablet, delayed release in 1 bottle62756-797-88Sun Pharmaceutical IndustriesIndia29 July 2008
100 tablet, delayed release in 1 bottle, plastic29300-139-01Unichem LaboratoriesIndia1 October 2011
500 tablet, delayed release in 1 bottle, plastic29300-139-05Unichem LaboratoriesIndia1 October 2011
1000 tablet, delayed release in 1 bottle, plastic29300-139-10Unichem LaboratoriesIndia1 October 2011
30 tablet, delayed release in 1 bottle69452-434-13Bionpharma26 June 2024
100 tablet, delayed release in 1 bottle69452-434-20Bionpharma26 June 2024
500 tablet, delayed release in 1 bottle69452-434-30Bionpharma26 June 2024
100 tablet, delayed release in 1 bottle57237-047-01Rising Pharma Holdings24 October 2014
500 tablet, delayed release in 1 bottle57237-047-05Rising Pharma Holdings24 October 2014
100 blister pack in 1 carton / 1 tablet, delayed release in 1 blister pack0832-7123-01Upsher-Smith Laboratories1 April 2016
100 tablet, delayed release in 1 bottle0832-7123-11Upsher-Smith Laboratories21 March 2014
500 tablet, delayed release in 1 bottle0832-7123-15Upsher-Smith Laboratories21 March 2014
30 tablet, delayed release in 1 bottle71335-0008-1Bryant Ranch Prepack21 December 2018
60 tablet, delayed release in 1 bottle71335-0008-2Bryant Ranch Prepack6 March 2018
90 tablet, delayed release in 1 bottle71335-0008-3Bryant Ranch Prepack1 March 2018
120 tablet, delayed release in 1 bottle71335-0008-4Bryant Ranch Prepack27 December 2021
30 tablet, delayed release in 1 bottle71335-2277-1Bryant Ranch Prepack29 November 2023
60 tablet, delayed release in 1 bottle71335-2277-2Bryant Ranch Prepack30 May 2024
90 tablet, delayed release in 1 bottle71335-2277-3Bryant Ranch Prepack30 May 2024
120 tablet, delayed release in 1 bottle71335-2277-4Bryant Ranch Prepack30 May 2024
30 tablet, delayed release in 1 bottle71335-2783-1Bryant Ranch Prepack13 October 2025
60 tablet, delayed release in 1 bottle71335-2783-2Bryant Ranch Prepack13 October 2025
90 tablet, delayed release in 1 bottle71335-2783-3Bryant Ranch Prepack13 October 2025
120 tablet, delayed release in 1 bottle71335-2783-4Bryant Ranch Prepack13 October 2025
100 tablet, delayed release in 1 bottle71335-2783-5Bryant Ranch Prepack13 October 2025
100 tablet, delayed release in 1 bottle71335-2862-1Bryant Ranch Prepack23 October 2025
500 tablet, delayed release in 1 bottle71335-2885-1Bryant Ranch Prepack23 October 2025

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 10 March 1983Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Divalproex 250 mg delayed-release tablet.

Compare 1

Other strengths and forms of Divalproex

Clinical summary

Divalproex is an anti-epileptic agent indicated for treatment of manic episodes associated with bipolar disorder, among other approved uses. It is available as delayed-release tablets, extended-release tablets and capsules for oral use. MedsAcross supplies Divalproex for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Divalproex

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Divalproex 250 mg delayed-release tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.